• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对映体拆分和手性 δ-内酰胺的绝对构型,一种用于合成生物活性化合物的有用中间体。

Enantiomeric Resolution and Absolute Configuration of a Chiral δ-Lactam, Useful Intermediate for the Synthesis of Bioactive Compounds.

机构信息

Department of Drug Sciences, University of Pavia, via Taramelli 12, 27100 Pavia, Italy.

Centro Grandi Strumenti, University of Pavia, via Bassi 21, 27100 Pavia, Italy.

出版信息

Molecules. 2020 Dec 19;25(24):6023. doi: 10.3390/molecules25246023.

DOI:10.3390/molecules25246023
PMID:33352660
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7766352/
Abstract

During the past several years, the frequency of discovery of new molecular entities based on γ- or δ-lactam scaffolds has increased continuously. Most of them are characterized by the presence of at least one chiral center. Herein, we present the preparation, isolation and the absolute configuration assignment of enantiomeric 2-(4-bromophenyl)-1-isobutyl-6-oxopiperidin-3-carboxylic acid (-). For the preparation of racemic -, the Castagnoli-Cushman reaction was employed. (Semi)-preparative enantioselective HPLC allowed to obtain enantiomerically pure - whose absolute configuration was assigned by X-ray diffractometry. Compound (+)-()- represents a reference compound for the configurational study of structurally related lactams.

摘要

在过去的几年中,基于 γ-或 δ-内酰胺骨架的新分子实体的发现频率不断增加。它们大多数的特点是至少存在一个手性中心。在这里,我们介绍了对映体 2-(4-溴苯基)-1-异丁基-6-氧代哌啶-3-羧酸(-)的制备、分离和绝对构型分配。对于外消旋 - 的制备,采用了 Castagnoli-Cushman 反应。(半)制备性对映体选择性 HPLC 允许获得对映体纯的 -,其绝对构型通过 X 射线衍射法确定。化合物 (+)-()- 是对结构相关内酰胺进行构型研究的参考化合物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca52/7766352/e69313ecfad8/molecules-25-06023-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca52/7766352/55e78ba8bc5d/molecules-25-06023-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca52/7766352/4249b585d3d6/molecules-25-06023-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca52/7766352/ab491fc6fec2/molecules-25-06023-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca52/7766352/45bafb6e8f99/molecules-25-06023-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca52/7766352/15987ee75b38/molecules-25-06023-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca52/7766352/eb0e67b1b1de/molecules-25-06023-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca52/7766352/d4d72f45a739/molecules-25-06023-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca52/7766352/2b31a79a6260/molecules-25-06023-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca52/7766352/97b955f65ebd/molecules-25-06023-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca52/7766352/e69313ecfad8/molecules-25-06023-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca52/7766352/55e78ba8bc5d/molecules-25-06023-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca52/7766352/4249b585d3d6/molecules-25-06023-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca52/7766352/ab491fc6fec2/molecules-25-06023-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca52/7766352/45bafb6e8f99/molecules-25-06023-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca52/7766352/15987ee75b38/molecules-25-06023-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca52/7766352/eb0e67b1b1de/molecules-25-06023-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca52/7766352/d4d72f45a739/molecules-25-06023-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca52/7766352/2b31a79a6260/molecules-25-06023-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca52/7766352/97b955f65ebd/molecules-25-06023-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca52/7766352/e69313ecfad8/molecules-25-06023-sch003.jpg

相似文献

1
Enantiomeric Resolution and Absolute Configuration of a Chiral δ-Lactam, Useful Intermediate for the Synthesis of Bioactive Compounds.对映体拆分和手性 δ-内酰胺的绝对构型,一种用于合成生物活性化合物的有用中间体。
Molecules. 2020 Dec 19;25(24):6023. doi: 10.3390/molecules25246023.
2
Novel Enantiopure Sigma Receptor Modulators: Quick (Semi-)Preparative Chiral Resolution via HPLC and Absolute Configuration Assignment.新型对映体纯西格玛受体调节剂:通过高效液相色谱法进行快速(半)制备型手性拆分及绝对构型确定
Molecules. 2016 Sep 10;21(9):1210. doi: 10.3390/molecules21091210.
3
Enantiomeric high-performance liquid chromatography resolution and absolute configuration of 6β-benzoyloxy-3α-tropanol.6β-苯甲酰氧基-3α-托烷醇的对映体高效液相色谱拆分及绝对构型
J Sep Sci. 2016 Jul;39(14):2720-7. doi: 10.1002/jssc.201600061. Epub 2016 Jun 27.
4
Analytical and semi-preparative HPLC enantioseparation of novel pyridazin-3(2H)-one derivatives with α-aminophosphonate moiety using immobilized polysaccharide chiral stationary phases.新型含α-氨基膦酸酯部分的吡啶并[3,2-h]-1,2,4-三嗪-3(2H)-酮衍生物的手性固定相高效液相色谱分析和半制备拆分。
J Sep Sci. 2011 Feb;34(4):402-8. doi: 10.1002/jssc.201000705. Epub 2011 Jan 18.
5
Enantioselective chromatography and absolute configuration of N,N-dimethyl-3-(naphthalen-2-yl)-butan-1-amines: potential sigma1 ligands.N,N-二甲基-3-(萘-2-基)丁-1-胺的对映体选择性色谱分析及绝对构型:潜在的σ1配体
Chirality. 2006 May 5;18(4):245-53. doi: 10.1002/chir.20227.
6
Laboratory-Scale Preparative Enantioseparations of Pharmaceutically Relevant Compounds on Commercially Available Chiral Stationary Phases for HPLC.利用市售高效液相色谱手性固定相进行药学相关化合物的实验室规模制备对映体分离
Curr Med Chem. 2017;24(8):796-817. doi: 10.2174/0929867323666160907111107.
7
Preparative enantiomeric separation of new selective CB2 receptor agonists by liquid chromatography on polysaccharide-based chiral stationary phases: determination of enantiomeric purity and assignment of absolute stereochemistry by X-ray structure analysis.采用多糖手性固定相高效液相色谱法对新型选择性 CB2 受体激动剂进行制备对映体拆分:通过 X 射线结构分析测定对映体纯度和绝对立体化学构型。
Chirality. 2011 May;23(5):389-96. doi: 10.1002/chir.20939. Epub 2011 Mar 23.
8
Synthesis, chiral HPLC resolution and configuration assignment of 1-phenylglyceryl trinitrate stereomers.1-苯基甘油三硝酸酯立体异构体的合成、手性高效液相色谱拆分及构型确定
Chirality. 2006 Jun;18(6):430-6. doi: 10.1002/chir.20278.
9
[Study on the screening of lactamase and its fermentation conditions].[内酰胺酶的筛选及其发酵条件的研究]
Wei Sheng Wu Xue Bao. 2006 Aug;46(4):571-5.
10
The Synthesis and Absolute Configuration of Enantiomeric Pure (R)- and (S)-3-(piperidin-3-yl)-1H-Indole Derivatives.(R)-和(S)-3-(哌啶-3-基)-1H-吲哚衍生物的立体纯对映异构体的合成与绝对构型。
Int J Mol Sci. 2022 Dec 28;24(1):517. doi: 10.3390/ijms24010517.

引用本文的文献

1
1,3-Dithiolane as a Privileged Scaffold in Bioactive Derivatives: Chiral Resolution and Assignment of Absolute Configuration.1,3-二硫戊环作为生物活性衍生物中的优势骨架:手性拆分与绝对构型的确定
Int J Mol Sci. 2024 Nov 29;25(23):12880. doi: 10.3390/ijms252312880.
2
From Nature to Synthetic Compounds: Novel 1(N),2,3 Trisubstituted-5-oxopyrrolidines Targeting Multiple Myeloma Cells.从天然产物到合成化合物:新型靶向多发性骨髓瘤细胞的 1(N),2,3-三取代-5-氧代吡咯烷。
Int J Mol Sci. 2022 Oct 27;23(21):13061. doi: 10.3390/ijms232113061.
3
Anti-Multiple Myeloma Potential of Secondary Metabolites from -Part 2.

本文引用的文献

1
Exploring the chemical space and the bioactivity profile of lactams: a chemoinformatic study.探索内酰胺的化学空间和生物活性概况:一项化学信息学研究。
RSC Adv. 2019 Aug 28;9(46):27105-27116. doi: 10.1039/c9ra04841c. eCollection 2019 Aug 23.
2
Transition metal-free domino acyl substitution/Michael addition of alkenyl Grignard reagents to lactam esters: synthesis of lactam-bearing homoallylic ketones.无过渡金属催化的多米诺酰基取代/烯基格氏试剂对内酰胺酯的迈克尔加成反应:含内酰胺的高烯丙基酮的合成
RSC Adv. 2020 Jun 11;10(38):22454-22459. doi: 10.1039/d0ra03885g. eCollection 2020 Jun 10.
3
Synthesis of 1,3-diaryl-spiro[azetidine-2,3'-indoline]-2',4-diones the Staudinger reaction: - or -diastereoselectivity with different addition modes.
抗多发性骨髓瘤的次生代谢产物的潜力 - 第 2 部分。
Molecules. 2021 Oct 31;26(21):6596. doi: 10.3390/molecules26216596.
1,3-二芳基-螺[氮杂环丁烷-2,3'-吲哚啉]-2',4-二酮的合成:施陶丁格反应——不同加成模式下的 - 或 - 非对映选择性。
RSC Adv. 2020 Apr 6;10(24):14122-14133. doi: 10.1039/d0ra02374d.
4
BOPC1 Enantiomers Preparation and HuR Interaction Study. From Molecular Modeling to a Curious DEEP-STD NMR Application.BOPC1对映体的制备及与HuR的相互作用研究。从分子模拟到奇特的深度STD NMR应用。
ACS Med Chem Lett. 2020 Jan 28;11(5):883-888. doi: 10.1021/acsmedchemlett.9b00659. eCollection 2020 May 14.
5
Design, Synthesis, and Evaluation of Novel Anti-Trypanosomal Compounds.新型抗锥虫化合物的设计、合成与评价
Tetrahedron. 2020 Apr 17;76(16). doi: 10.1016/j.tet.2020.131086. Epub 2020 Mar 3.
6
Discovery of deoxylimonin δ-lactam derivative with favorable anti-inflammation and antinociception efficacy from chemical modified limonin/deoxylimonin analogs.从化学修饰的柠檬苦素/脱氧柠檬苦素类似物中发现具有良好抗炎和镇痛功效的去氧柠檬素 δ-内酰胺衍生物。
Bioorg Chem. 2020 Jul;100:103886. doi: 10.1016/j.bioorg.2020.103886. Epub 2020 Apr 24.
7
Insight into GEBR-32a: Chiral Resolution, Absolute Configuration and Enantiopreference in PDE4D Inhibition.深入了解 GEBR-32a:在 PDE4D 抑制中对映体拆分、绝对构型和对映体偏爱。
Molecules. 2020 Feb 19;25(4):935. doi: 10.3390/molecules25040935.
8
Therapies for rare diseases: therapeutic modalities, progress and challenges ahead.罕见病治疗方法:治疗方式、进展及未来挑战。
Nat Rev Drug Discov. 2020 Feb;19(2):93-111. doi: 10.1038/s41573-019-0049-9. Epub 2019 Dec 13.
9
Discovery of γ-lactam derivatives containing 1,3-benzodioxole unit as potential anti-phytopathogenic fungus agents.发现含有 1,3-苯并二恶茂单元的γ-内酰胺衍生物作为潜在的抗植物病原真菌剂。
Bioorg Med Chem Lett. 2020 Jan 15;30(2):126826. doi: 10.1016/j.bmcl.2019.126826. Epub 2019 Dec 3.
10
Glechomanamides A-C, Germacrane Sesquiterpenoids with an Unusual Δ-7,12-Lactam Moiety from and Their Antiangiogenic Activity.格莱克曼酰胺 A-C,来自 的具有不寻常 Δ-7,12-内酰胺部分的倍半萜类化合物及其抗血管生成活性。
J Nat Prod. 2019 Nov 22;82(11):3056-3064. doi: 10.1021/acs.jnatprod.9b00648. Epub 2019 Oct 31.